Three-dimensional computerised analysis of epithelial cell proliferation in the gastrointestinal tract.

by Hamilton, P. W., Williamson, K. E., Grimes, J., Arthur, K., Wilson, R. H.
Published 1994

A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea

by Coyle, V M, Lungulescu, D, Toganel, C, Niculescu, A, Pop, S, Ciuleanu, T, Cebotaru, C, Devane, J, Martin, M, Wilson, R H
Published 2013

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial

by Madi, A, Fisher, D, Wilson, R H, Adams, R A, Meade, A M, Kenny, S L, Nichols, L L, Seymour, M T, Wasan, H, Kaplan, R, Maughan, T S
Published 2012

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study

by Gormley, J A, Hegarty, S M, O'Grady, A, Stevenson, M R, Burden, R E, Barrett, H L, Scott, C J, Johnston, J A, Wilson, R H, Kay, E W, Johnston, P G, Olwill, S A
Published 2011

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, p...

by Glasspool, R M, Brown, R, Gore, M E, Rustin, G J S, McNeish, I A, Wilson, R H, Pledge, S, Paul, J, Mackean, M, Hall, G D, Gabra, H, Halford, S E R, Walker, J, Appleton, K, Ullah, R, Kaye, S
Published 2014

A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised m...

by Maughan, T S, Meade, A M, Adams, R A, Richman, S D, Butler, R, Fisher, D, Wilson, R H, Jasani, B, Taylor, G R, Williams, G T, Sampson, J R, Seymour, M T, Nichols, L L, Kenny, S L, Nelson, A, Sampson, C M, Hodgkinson, E, Bridgewater, J A, Furniss, D L, Roy, R, Pope, M J, Pope, J K, Parmar, M, Quirke, P, Kaplan, R
Published 2014